|
1
|
Global Burden of Disease Liver Cancer
Collaboration, ; Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu
MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, et al: The
burden of primary liver cancer and underlying etiologies from 1990
to 2015 at the global, regional, and national level: Results from
the global burden of disease study 2015. JAMA Oncol. 3:1683–1691.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma SA, Kowgier M, Hansen BE, Brouwer
WP, Maan R, Wong D, Shah H, Khalili K, Yim C, Heathcote EJ, et al:
Toronto HCC risk index: A validated scoring system to predict
10-year risk of HCC in patients with cirrhosis. J Hepatol. Aug
24–2017.(Online ahead of print).
|
|
5
|
Zhou L, Rui JA, Wang SB, Chen SG and Qu Q:
Risk factors of microvascular invasion, portal vein tumor
thrombosis and poor post-resectional survival in HBV-related
hepatocellular carcinoma. Hepatogastroenterology. 61:1696–1703.
2014.PubMed/NCBI
|
|
6
|
Giannelli G, Koudelkova P, Dituri F and
Mikulits W: Role of epithelial to mesenchymal transition in
hepatocellular carcinoma. J Hepatol. 65:798–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaufhold S and Bonavida B: Central role of
Snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res. 33:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan K, Xie K, Lan T, Xu L, Chen X, Li X,
Liao M, Li J, Huang J, Zeng Y and Wu H: TXNDC12 promotes EMT and
metastasis of hepatocellular carcinoma cells via activation of
β-catenin. Cell Death Differ. 27:1355–1368. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma M, Xu H, Liu G, Wu J, Li C, Wang X,
Zhang S, Xu H, Ju S, Cheng W, et al: Metabolism-induced tumor
activator 1 (MITA1), an energy stress-inducible long noncoding RNA,
promotes hepatocellular carcinoma metastasis. Hepatology.
70:215–230. 2019.PubMed/NCBI
|
|
12
|
Peng JM, Bera R, Chiou CY, Yu MC, Chen TC,
Chen CW, Wang TR, Chiang WL, Chai SP, Wei Y, et al: Actin
cytoskeleton remodeling drives epithelial-mesenchymal transition
for hepatoma invasion and metastasis in mice. Hepatology.
67:2226–2243. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wan S, Meyer AS, Weiler SME, Rupp C, Tóth
M, Sticht C, Singer S, Thomann S, Roessler S, Schorpp-Kistner M, et
al: Cytoplasmic localization of the cell polarity factor scribble
supports liver tumor formation and tumor cell invasiveness.
Hepatology. 67:1842–1856. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW,
Wang Z, Fan J, Dai Z and Zhou J: CXCR2/CXCL5 axis contributes to
epithelial-mesenchymal transition of HCC cells through activating
PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett. 358:124–135. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui D, Zhao Y and Xu J: Activated
CXCL5-CXCR2 axis promotes the migration, invasion and EMT of
papillary thyroid carcinoma cells via modulation of β-catenin
pathway. Biochimie. 148:1–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Chen JX, Chen Y, Cai LL, Wang XZ,
Guo WH and Zheng JF: The chemokine receptor CCR10 promotes
inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway
activation. Cell Death Dis. 9:2322018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tavares J, Formaglio P, Thiberge S,
Mordelet E, Van Rooijen N, Medvinsky A, Ménard R and Amino R: Role
of host cell traversal by the malaria sporozoite during liver
infection. J Exp Med. 210:905–915. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Odedra A, Webb L, Marquart L, Britton LJ,
Chalon S, Moehrle JJ, Anstey NM, William T, Grigg MJ, Lalloo DG, et
al: Liver function test abnormalities in experimental and clinical
Plasmodium vivax infection. Am J Trop Med Hyg.
103:1910–1917. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin L, Chen C, Chen L, Xue R, Ou-Yang M,
Zhou C, Zhao S, He Z, Xia Y, He J, et al: Worldwide malaria
incidence and cancer mortality are inversely associated. Infect
Agent Cancer. 12:142017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Adah D, Yang Y, Liu Q, Gadidasu K, Tao Z,
Yu S, Dai L, Li X, Zhao S, Qin L, et al: Plasmodium
infection inhibits the expansion and activation of MDSCs and Tregs
in the tumor microenvironment in a murine Lewis lung cancer model.
Cell Commun Signal. 17:322019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi X, Qin L, Liu G, Zhao S, Peng N and
Chen X: Dynamic balance of pSTAT1 and pSTAT3 in C57BL/6 mice
infected with lethal or nonlethal Plasmodium yoelii. Cell
Mol Immunol. 5:341–348. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, He Z, Qin L, Li Q, Shi X, Zhao S,
Chen L, Zhong N and Chen X: Antitumor effect of malaria parasite
infection in a murine Lewis lung cancer model through induction of
innate and adaptive immunity. PLoS One. 6:e244072011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Q, Yang Y, Tan X, Tao Z, Adah D, Yu S,
Lu J, Zhao S, Qin L, Qin L and Chen X: Plasmodium parasite
as an effective hepatocellular carcinoma antigen glypican-3
delivery vector. Oncotarget. 8:24785–24796. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Liu Q, Lu J, Adah D, Yu S, Zhao S,
Yao Y, Qin L, Qin L and Chen X: Exosomes from
Plasmodium-infected hosts inhibit tumor angiogenesis in a
murine Lewis lung cancer model. Oncogenesis. 6:e3512017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Li Q, Wang J, Zhao S, Nashun B,
Qin L and Chen X: Plasmodium infection inhibits tumor
angiogenesis through effects on tumor-associated macrophages in a
murine implanted hepatoma model. Cell Commun Signal. 18:1572020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
R Core Team: R: A language and environment
for statistical computing. R Foundation for Statistical Computing;
Vienna: 2014, PubMed/NCBI
|
|
28
|
Levesque MA, Sullivan AD and Meshnick SR:
Splenic and hepatic hemozoin in mice after malaria parasite
clearance. J Parasitol. 85:570–573. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barrallo-Gimeno A and Nieto MA: The Snail
genes as inducers of cell movement and survival: Implications in
development and cancer. Development. 132:3151–3161. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Buonaguro L, Mauriello A, Cavalluzzo B,
Petrizzo A and Tagliamonte M: Immunotherapy in hepatocellular
carcinoma. Ann Hepatol. 18:291–297. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eger A, Aigner K, Sonderegger S, Dampier
B, Oehler S, Schreiber M, Berx G, Cano A, Beug H and Foisner R:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elich M and Sauer K: Regulation of
hematopoietic cell development and function through
phosphoinositides. Front Immunol. 9:9312018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang C, Wei S, Sun WP, Teng K, Dai MM,
Wang FW, Chen JW, Ling H, Ma XD, Feng ZH, et al:
Super-enhancer-driven AJUBA is activated by TCF4 and involved in
epithelial-mesenchymal transition in the progression of
hepatocellular carcinoma. Theranostics. 10:9066–9082. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee YJ and Han HJ: Troglitazone
ameliorates high glucose-induced EMT and dysfunction of SGLTs
through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal
tubule cells. Am J Physiol Renal Physiol. 298:F1263–F1275. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liang Y, Jing Z, Deng H, Li Z, Zhuang Z,
Wang S and Wang Y: Soluble epoxide hydrolase inhibition ameliorates
proteinuria-induced epithelial-mesenchymal transition by regulating
the PI3K-Akt-GSK-3β signaling pathway. Biochem Biophys Res Commun.
463:70–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Amarandi RM, Hjortø GM, Rosenkilde MM and
Karlshøj S: Probing biased signaling in chemokine receptors.
Methods Enzymol. 570:155–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zweemer AJM, Toraskar J, Heitman LH and
Ijzerman AP: Bias in chemokine receptor signalling. Trends Immunol.
35:243–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Roh YS and Seki E: Chemokines and
chemokine receptors in the development of NAFLD. Adv Exp Med Biol.
1061:45–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ridiandries A, Tan JTM and Bursill CA: The
role of chemokines in wound healing. Int J Mol Sci. 19:32172018.
View Article : Google Scholar
|
|
43
|
Kieseier BC, Tani M, Mahad D, Oka N, Ho T,
Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM and Hartung HP:
Chemokines and chemokine receptors in inflammatory demyelinating
neuropathies: A central role for IP-10. Brain. 125:823–834. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Marcuzzi E, Angioni R, Molon B and Calì B:
Chemokines and chemokine receptors: Orchestrating tumor
metastasization. Int J Mol Sci. 20:962018. View Article : Google Scholar
|
|
45
|
Lin HY, Sun SM, Lu XF, Chen PY, Chen CF,
Liang WQ and Peng CY: CCR10 activation stimulates the invasion and
migration of breast cancer cells through the ERK1/2/MMP-7 signaling
pathway. Int Immunopharmacol. 51:124–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Monteagudo C, Ramos D, Pellín-Carcelén A,
Gil R, Callaghan RC, Martín JM, Alonso V, Murgui A, Navarro L,
Calabuig S, et al: CCL27-CCR10 and CXCL12-CXCR4 chemokine
ligand-receptor mRNA expression ratio: New predictive factors of
tumor progression in cutaneous malignant melanoma. Clin Exp
Metastasis. 29:625–637. 2012. View Article : Google Scholar : PubMed/NCBI
|
